PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats.
about
A High-Protein Diet Reduces Weight Gain, Decreases Food Intake, Decreases Liver Fat Deposition, and Improves Markers of Muscle Metabolism in Obese Zucker Rats.Rapamycin-induced metabolic defects are reversible in both lean and obese miceEvidence for the Presence of Glucosensor Mechanisms Not Dependent on Glucokinase in Hypothalamus and Hindbrain of Rainbow Trout (Oncorhynchus mykiss)Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on OutcomesLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.Exposure of pregnant mice to triclosan impairs placental development and nutrient transportmTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation.About-face on the metabolic side effects of rapamycin.Adipocyte mTORC1 deficiency promotes adipose tissue inflammation and NLRP3 inflammasome activation via oxidative stress and de novo ceramide synthesis.Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPARγ-dependent and PPARγ-independent actions.Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.Acute rapamycin treatment improved glucose tolerance through inhibition of hepatic gluconeogenesis in rainbow trout (Oncorhynchus mykiss).
P2860
Q33851987-963E6C10-8794-4E25-9470-EB0BB8054FE2Q34461128-3C4CF839-B370-4A51-B0F3-7375F443B542Q35634329-9CD99BE0-8D74-4E1B-8753-D4E1247ED5E9Q36411111-D49E09A9-D70E-45B0-B0EE-799C7681992FQ36541052-3F6C589E-994F-42B6-8F01-C70B0D13F4A9Q37235568-913AAA46-D762-43E5-8D09-2943714E927FQ37713031-F0B0FAA7-B3A9-4A75-B6DF-0B4438F98140Q38962103-42D48F57-2328-4B47-89FC-3EF139D8D2A5Q42042549-2924014E-523A-41D7-A564-18CE82B732D1Q42583065-8F4D9C0A-6300-4D85-B9F6-45BFEB87A482Q50906435-746E91A4-5CAD-4453-88ED-9A63CE567845Q51308553-1ADDBF17-8EA6-4EF6-8E19-5663920E584DQ51734662-D7241F1D-6675-473A-B2EB-58AAFB12E2B9Q55071571-B7E16520-4359-4429-B0BE-5D1E89E813F7
P2860
PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
PPARγ activation attenuates gl ...... bition with rapamycin in rats.
@en
PPARγ activation attenuates gl ...... bition with rapamycin in rats.
@nl
type
label
PPARγ activation attenuates gl ...... bition with rapamycin in rats.
@en
PPARγ activation attenuates gl ...... bition with rapamycin in rats.
@nl
prefLabel
PPARγ activation attenuates gl ...... bition with rapamycin in rats.
@en
PPARγ activation attenuates gl ...... bition with rapamycin in rats.
@nl
P2093
P2860
P50
P1476
PPARγ activation attenuates gl ...... ibition with rapamycin in rats
@en
P2093
André Marette
Angelo Carpinelli
Juliana Magdalon
Philippe St-Pierre
Pierre-Gilles Blanchard
Thiago Belchior
Vivian A Paschoal
Yves Deshaies
P2860
P304
P356
10.1152/AJPENDO.00683.2013
P577
2014-03-11T00:00:00Z